High-dose ursodeoxycholic acid increases risk of adverse outcomes in patients with early stage primary sclerosing cholangitis

✍ Scribed by M. H. Imam; E. Sinakos; A. A. Gossard; K. V. Kowdley; V. A. C. Luketic; M. Edwyn Harrison; T. McCashland; A. S. Befeler; D. Harnois; R. Jorgensen; J. Petz; J. Keach; A. C. DeCook; F. Enders; K. D. Lindor

• Book ID: 111754309
• Publisher: John Wiley and Sons
• Year: 2011
• Tongue: English
• Weight: 226 KB
• Volume: 34
• Category: Article
• ISSN: 0269-2813
• DOI: 10.1111/j.1365-2036.2011.04863.x